why choose us

First received: July 15, 2022

Clinical Trial: Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC

Study Status: Completed

Recruit Status: RECRUITING

Condition: Breast Cancer Recurrent

Study Type: INTERVENTIONAL


Official Title: Towards Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of Triple Negative Breast Cancer

Brief Summary: This is a prospective phase 2 study to use Functional Precision Oncology (FPO) to predict, prevent and treat early metastatic recurrence in subjects with HR-low/Her2 negative or triple negative breast cancer.

Read more